NewGenIvf Group Ltd.’s board approved a 1-for-4 reverse stock split of all issued and unissued shares, including its Nasdaq-listed Class A ordinary shares. The consolidation takes effect at 12:01 a.m. ET on March 16, 2026, with trading on a split-adjusted basis beginning at the market open the same day under the symbol NIVF and a new CUSIP, G0544E147. The split is expected to reduce outstanding Class A shares from 2,273,790 to about 568,323, and outstanding options, warrants and other convertibles will be adjusted accordingly.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NewGenIvf Group Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-025957), on March 11, 2026, and is solely responsible for the information contained therein.
Comments